Articles

Export 7 results:

Filters: Keyword is NOD [Clear All Filters]

2012

Holmes N, Cooke A. 2012. Genetic Analysis of Type 1 Diabetes: Embryonic Stem Cells as New Tools to Unlock Biological Mechanisms in Type 1 Diabetes. The Review of Diabetic Studies. 9(4):137-147.

PDF (170.47 KB)

Zaccone P, Hall SW. 2012. Helminth Infection and Type 1 Diabetes. The Review of Diabetic Studies. 9(4):272-286.

PDF (851.53 KB)

F Wong S, Wen L. 2012. Type 1 Diabetes Therapy Beyond T Cell Targeting: Monocytes, B Cells, and Innate Lymphocytes. The Review of Diabetic Studies. 9(4):289-304.

PDF (823.03 KB)

2009

Shimada A, Oikawa Y, Yamada Y, Okubo Y. 2009. The Role of the CXCL10/CXCR3 System in Type 1 Diabetes. The Review of Diabetic Studies. 6(2):81-84.

PDF (123.18 KB)

Phillips JM, Parish NM, Raine T, Bland C, Sawyer Y, De La Peña H, Cooke A. 2009. Type 1 Diabetes Development Requires Both CD4+ and CD8+ T cells and Can Be Reversed by Non-Depleting Antibodies Targeting Both T Cell Populations. The Review of Diabetic Studies. 6(2):97-103.

PDF (231.34 KB)

Phillips JM, Parish NM, Raine T, Bland C, Sawyer Y, De La Peña H, Cooke A. 2009. Type 1 Diabetes Development Requires Both CD4+ and CD8+ T cells and Can Be Reversed by Non-Depleting Antibodies Targeting Both T Cell Populations. The Review of Diabetic Studies. 6(2):97-103.

RevDiabeticStud-6-2-97.pdf (231.34 KB)

2004

Fletcher JM, Jordan MA, Baxter AG. 2004. Type 1 Diabetes and NKT Cells: A Report on the 3rd International Workshop on NKT Cells and CD1-Mediated Antigen Presentation, September 2004, Heron Island, QLD, Australia. The Review of Diabetic Studies. 1(3):141-144.

PDF (178.49 KB)